NPS Intelligence (beta)

Disclosed NPS & retention by vertical

Verticals  /  Pharma, medtech & health distribution  /  IDEXX Laboratories

IDEXX Laboratories

Pharma, medtech & health distributionVeterinary DiagnosticsIDXX
idexx.com ↗
57
Latest disclosed NPS
27 Mar 2026
4
NPS entries
1 with a number
95%
Retention
2 Feb 2026
2016–26
Years covered
31 entries in all

In their words

“Customer retention remains in the high nineties for our global CAG Diagnostics business.”
— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2025 · 2 Feb 2026
“Sustained high levels of customer retention in the high 90s across our diagnostic modalities.”
— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q1 2025 · 1 May 2025
“Exceptional customer retention rates of over 97%, ensuring that practices continue to see IDEXX as an indispensable partner.”
— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2024 · 3 Feb 2025

NPS disclosures (4)

Search the database →

27 Mar 2026
NPS57

…expansions in Australia, Germany and the United Kingdom, while expanding our U.S. field-based resources; + Achieved a Net Promoter Score of 57 from our U.S. veterinary practice customers; + Maintained customer retention in the high 90s within…

— IDEXX Laboratories · SEC proxy statement · filed 27 Mar 2026
SEC proxy statement ↗
1 Aug 2023
NPSProgram

The result of these efforts is an excellent customer experience, which helped earn a world-class NPS rating for our diagnostic imaging business, one proof point of the solid overall experience that customers of all types have with IDEXX.

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q2 2023 · 1 Aug 2023
Earnings call, Q2 2023 ↗
6 Feb 2023
NPSProgram

And in turn, our customers reward us with high retention levels and world-class NPS scores for our products and services. This customer-first mindset is fundamental to our strategy and we look forward to bringing it to our work on a daily basis in 2023.

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2022 · 6 Feb 2023
Earnings call, Q4 2022 ↗
31 Mar 2022
NPSProgram

…experience enabling technologies, including Salesforce Service Cloud for the CAG business in North America. ◦ Achieved a world-class Net Promoter Score in the U.S. and industry leading customer satisfaction survey results in the U.S. on several…

— IDEXX Laboratories · SEC proxy statement · filed 31 Mar 2022
SEC proxy statement ↗

Retention disclosures (27)

Open in the retention database →

2 Oct 2026
Retention

IDEXX acquires veterinary AI platform CoVet; integration of AI scribe technology can boost net revenue retention through upsell of advanced analytics.

— reported by saasrise.com · 2 Oct 2026
saasrise.com ↗
2 Feb 2026
Retention95%

Retention rate (global CAG Diagnostics): 95% (Q4 2025) — “Customer retention remains in the high nineties for our global CAG Diagnostics business.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2025 · 2 Feb 2026
Earnings call, Q4 2025 ↗
1 May 2025
Retention95%

Retention rate: 95% (Q1 2025) — “sustained high levels of customer retention in the high 90s across our diagnostic modalities.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q1 2025 · 1 May 2025
Earnings call, Q1 2025 ↗
28 Mar 2025
Retention97%

Retention rate (CAG Diagnostics): 97% (FY2024) — “Sustained high (97%+) customer retention rate within our key CAG Diagnostics business”

— IDEXX Laboratories · SEC proxy statement · filed 28 Mar 2025
SEC proxy statement ↗
3 Feb 2025
Retention97%

Retention rate: 97% (Q4 2024) — “exceptional customer retention rates of over 97%, ensuring that practices continue to see IDEXX as an indispensable partner.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2024 · 3 Feb 2025
Earnings call, Q4 2024 ↗
6 Aug 2024
Retention97%

Retention rate: 97% (Q2 2024) — “sustained high 97% plus customer retention rates.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q2 2024 · 6 Aug 2024
Earnings call, Q2 2024 ↗
5 Feb 2024
Retention97%

Retention rate (US): 97% (Q4 2023) — “sustained customer retention rates in the 97% to 99% range for the US and, similarly, high levels globally.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2023 · 5 Feb 2024
Earnings call, Q4 2023 ↗
6 Feb 2023
Retention97%

Retention rate: 97% (Q4 2022) — “Customer retention rates remained at or above 97% across our major modalities throughout 2022.”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2022 · 6 Feb 2023
Earnings call, Q4 2022 ↗
1 Nov 2022
Retention98%

Retention rate (Catalyst): 98% (Q3 2022) — “continued sustained new business gains and 98% Catalyst customer retention rates”

— Jay Mazelsky, President and Chief Executive Officer, IDEXX Laboratories · Earnings call, Q3 2022 · 1 Nov 2022
Earnings call, Q3 2022 ↗
30 Jul 2021
Retention97%

Retention rate (Rapid Assay (Vector Borne Disease)): 97% (Q2 2021) — “core vector borne disease retention rates for U.S. rapid assay reached 97% in the quarter”

— Brian McKeon, Chief Financial Officer, IDEXX Laboratories · Earnings call, Q2 2021 · 30 Jul 2021
Earnings call, Q2 2021 ↗
26 Jul 2021
Retention96%

IDEXX Laboratories reported revenue growth of 45% over 5 years with improvements in customer retention levels over 96%.

— reported by seekingalpha.com · 26 Jul 2021
seekingalpha.com ↗
5 Jun 2021
Retention96%

IDEXX Web PACS achieved more than 96% improvement in customer retention levels following ezyVet acquisition.

— reported by nasdaq.com · 5 Jun 2021
nasdaq.com ↗
4 May 2021
Retention97%

Retention rate (Rapid Assay): 97% (Q1 2021) — “retention rates for U.S. rapid asset customers reached 97% in Q1, the highest level”

— Brian McKeon, Chief Financial Officer, IDEXX Laboratories · Earnings call, Q1 2021 · 4 May 2021
Earnings call, Q1 2021 ↗
24 Oct 2020
Retention

IDEXX Laboratories reported continued high customer retention in its animal diagnostic business in Q3.

— reported by finance.yahoo.com · 24 Oct 2020
finance.yahoo.com ↗
1 Aug 2020
Retentionup

IDEXX Laboratories reported high customer retention levels in Q2 2020, supported by high levels of service during the COVID-19 pandemic.

— reported by biospace.com · 1 Aug 2020
biospace.com ↗
1 May 2019
Retention98%

Retention rate (U.S. VetLab): 98% (Q1 2019) — “Customer retention rates in the U.S. remain stable and Q1 at world-class levels of 98% to 99%”

— Jon Ayers, Chief Executive Officer, IDEXX Laboratories · Earnings call, Q1 2019 · 1 May 2019
Earnings call, Q1 2019 ↗
1 Nov 2018
Retention97%

Retention rate (U.S.): 97% (Q3 2018) — “Overall customer retention trends in the U.S. continue at world-class levels of 97% to 98%”

— Jonathan W. Ayers - IDEXX Laboratories, Inc., Chief Executive Officer, IDEXX Laboratories · Earnings call, Q3 2018 · 1 Nov 2018
Earnings call, Q3 2018 ↗
1 Aug 2018
Retention97%

Retention rate (Reference Laboratory): 97% (Q2 2018) — “record high customer retention levels, now over 97%”

— Brian P. McKeon - IDEXX Laboratories, Inc., Chief Financial Officer, IDEXX Laboratories · Earnings call, Q2 2018 · 1 Aug 2018
Earnings call, Q2 2018 ↗
29 May 2018
Retentionup

IDEXX reports consistent customer retention driven by strong Catalyst product uptake and international market growth.

— reported by zacks.com · 29 May 2018
zacks.com ↗
1 Feb 2018
Retention97%

Retention rate (Reference Lab): 97% (Q4 2017) — “customer retention levels reaching 97% from the Reference Lab modality”

— Jonathan W. Ayers, Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2017 · 1 Feb 2018
Earnings call, Q4 2017 ↗
1 Feb 2018
Retention98%

Retention rate (U.S. in-house chemistry): 98% (Q4 2017) — “Our 98% retention of in-house chemistry accounts in U.S. compares favorably to any period”

— Jonathan W. Ayers, Chief Executive Officer, IDEXX Laboratories · Earnings call, Q4 2017 · 1 Feb 2018
Earnings call, Q4 2017 ↗
31 Oct 2017
Retention98%

Retention rate (International reference lab instrument consumables): 98% (Q3 2017) — “Customer retention rates internationally for reference lab instrument consumables are even higher, at 98% to 99%”

— Jonathan W. Ayers - IDEXX Laboratories, Inc., Chief Executive Officer, IDEXX Laboratories · Earnings call, Q3 2017 · 31 Oct 2017
Earnings call, Q3 2017 ↗
31 Oct 2017
Retention97%

Retention rate (U.S. CAG Diagnostics reference labs): 97% (Q3 2017) — “Customer retention rates for U.S. CAG Diagnostics recurring revenues remain at exceptional levels of 97% to 98% for reference labs”

— Jonathan W. Ayers - IDEXX Laboratories, Inc., Chief Executive Officer, IDEXX Laboratories · Earnings call, Q3 2017 · 31 Oct 2017
Earnings call, Q3 2017 ↗
2 Feb 2017
Retention98%

Retention rate (Catalyst): 98% (Q4 2016) — “Catalyst retention rates remain very high at 98%”

— Brian P. McKeon - IDEXX Laboratories, Inc., Chief Financial Officer, IDEXX Laboratories · Earnings call, Q4 2016 · 2 Feb 2017
Earnings call, Q4 2016 ↗
1 Nov 2016
Retention98%

Retention rate (U.S. consumable revenue (chemistry)): 98% (Q3 2016) — “U.S. consumable revenue retention rates, which are now tracking at 98% annualized”

— Brian P. McKeon - IDEXX Laboratories, Inc., Chief Financial Officer, IDEXX Laboratories · Earnings call, Q3 2016 · 1 Nov 2016
Earnings call, Q3 2016 ↗
2 Aug 2016
Retention99.9%

Retention rate (Water business): 99.9% (Q2 2016) — “Our Water business...99.9% customer retention”

— IDEXX Laboratories management · Earnings call, Q2 2016 · 2 Aug 2016
Earnings call, Q2 2016 ↗
2 Aug 2016
Retention97%

Retention rate (Overall instrument consumables): 97% (Q2 2016) — “continuing high 97% to 99% customer retention levels”

— Jonathan W. Ayers - Chairman, President & Chief Executive Officer, IDEXX Laboratories · Earnings call, Q2 2016 · 2 Aug 2016
Earnings call, Q2 2016 ↗

Lighthouse companies in Pharma, medtech & health distribution

The whole vertical →

About these figures

Every figure here was publicly disclosed by the named company: press releases, annual reports, SEC filings, earnings calls and news coverage. Companies tend to publish their NPS when it is good, so these numbers run higher than a true industry average: read them as what leading companies in this vertical say publicly, not as an industry benchmark.

NPS runs from −100 to +100. Retention figures are reported as the company defines them (net revenue retention, gross revenue retention, customer retention rate, churn). Every entry links to its source in the full database.